Exploring the association between melatonin and nicotine dependence (Review)
- Authors:
- Vasiliki Epameinondas Georgakopoulou
- Pagona Sklapani
- Nikolaos Trakas
- Russel J. Reiter
- Demetrios A. Spandidos
-
Affiliations: Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece, Department of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece, Department of Cell Systems and Anatomy, UT Health Science Center, San Antonio, TX 78229, USA, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece - Published online on: July 30, 2024 https://doi.org/10.3892/ijmm.2024.5406
- Article Number: 82
-
Copyright: © Georgakopoulou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Widysanto A, Combest FE, Dhakal A and Saadabadi A: Nicotine addiction (Updated 2023 Aug 8). StatPearls [Internet]. StatPearls Publishing; Treasure Island, FL: 2024 | |
|
Prochaska JJ and Benowitz NL: Current advances in research in treatment and recovery: Nicotine addiction. Sci Adv. 5:eaay97632019. View Article : Google Scholar : PubMed/NCBI | |
|
Onaolapo OJ and Onaolapo AY: Melatonin in drug addiction and addiction management: Exploring an evolving multidimensional relationship. World J Psychiatry. 8:64–74. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Picciotto MR and Kenny PJ: Mechanisms of nicotine addiction. Cold Spring Harb Perspect Med. 11:a0396102021. View Article : Google Scholar | |
|
Zhu J, Nelson K, Toth J and Muscat JE: Nicotine dependence as an independent risk factor for atherosclerosis in the national lung screening trial. BMC Public Health. 19:1032019. View Article : Google Scholar : PubMed/NCBI | |
|
Trakas N, Georgakopoulou VE, Melemeni D, Damaskos C, Mantzouranis K, Garmpis N, Gkoufa A, Papalexis P, Chlapoutakis S, Sklapani P, et al: Association between smoking cessation and alterations in forced expiratory volume in one second (FEV1). A follow-up study from a greek tobacco cessation clinic. Addict Health. 14:87–95. 2022.PubMed/NCBI | |
|
Masters A, Pandi-Perumal SR, Seixas A, Girardin JL and McFarlane SI: Melatonin, the hormone of darkness: From sleep promotion to ebola treatment. Brain Disord Ther. 4:10001512014. | |
|
Hardeland R, Madrid JA, Tan DX and Reiter RJ: Melatonin, the circadian multioscillator system and health: The need for detailed analyses of peripheral melatonin signaling. J Pineal Res. 52:139–166. 2012. View Article : Google Scholar | |
|
Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z and Reiter RJ: Melatonin as a potent and inducible endogenous antioxidant: Synthesis and metabolism. Molecules. 20:18886–18906. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Reiter RJ, Rosales-Corral SA, Tan DX, Acuna-Castroviejo D, Qin L, Yang SF and Xu K: Melatonin, a full service anti-cancer agent: Inhibition of initiation, progression and metastasis. Int J Mol Sci. 18:8432017. View Article : Google Scholar : PubMed/NCBI | |
|
Bocheva G, Slominski RM, Janjetovic Z, Kim TK, Böhm M, Steinbrink K, Reiter RJ, Kleszczyński K and Slominski AT: Protective role of melatonin and its metabolites in skin aging. Int J Mol Sci. 23:12382022. View Article : Google Scholar : PubMed/NCBI | |
|
Lempesis IG, Georgakopoulou VE, Reiter RJ and Spandidos DA: A mid-pandemic night's dream: Melatonin, from harbinger of anti-inflammation to mitochondrial savior in acute and long COVID-19 (Review). Int J Mol Med. 53:282024. View Article : Google Scholar : | |
|
Horton WJ, Gissel HJ, Saboy JE, Wright KP Jr and Stitzel JA: Melatonin administration alters nicotine preference consumption via signaling through high-affinity melatonin receptors. Psychopharmacology (Berl). 232:2519–2530. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Schiller ED, Champney TH, Reiter CK and Dohrman DP: Melatonin inhibition of nicotine-stimulated dopamine release in PC12 cells. Brain Res. 966:95–102. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Markus RP, Santos JM, Zago W and Reno LA: Melatonin nocturnal surge modulates nicotinic receptors and nicotine-induced [3H]glutamate release in rat cerebellum slices. J Pharmacol Exp Ther. 305:525–530. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Guo D, Wang J, Tian B, Li Y, Sun G and Zhang H: Exogenous melatonin alleviates NO2 damage in tobacco leaves by promoting antioxidant defense, modulating redox homeostasis, and signal transduction. J Hazard Mater. 424:1272652022. View Article : Google Scholar | |
|
Zhdanova IV and Piotrovskaya VR: Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans. Pharmacol Biochem Behav. 67:131–135. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX and Reiter RJ: Extrapineal melatonin: Sources, regulation, and potential functions. Cell Mol Life Sci. 71:2997–3025. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B and Hardeland R: Melatonin: Nature's most versatile biological signal? FEBS J. 273:2813–2838. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Xie X, Ding D, Bai D, Zhu Y, Sun W, Sun Y and Zhang D: Melatonin biosynthesis pathways in nature and its production in engineered microorganisms. Synth Syst Biotechnol. 7:544–553. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z, Sharma R and Reiter RJ: Melatonin synthesis and function: evolutionary history in animals and plants. Front Endocrinol (Lausanne). 10:2492019. View Article : Google Scholar : PubMed/NCBI | |
|
Zisapel N: New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 175:3190–3199. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Blume C, Garbazza C and Spitschan M: Effects of light on human circadian rhythms, sleep and mood. Somnologie (Berl). 23:147–156. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L and Zagrean AM: Melatonin's impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules. 10:12112020. View Article : Google Scholar : PubMed/NCBI | |
|
Kopustinskiene DM and Bernatoniene J: Molecular mechanisms of melatonin-mediated cell protection and signaling in health and disease. Pharmaceutics. 13:1292021. View Article : Google Scholar : PubMed/NCBI | |
|
Carrillo-Vico A, Reiter RJ, Lardone PJ, Herrera JL, Fernández-Montesinos R, Guerrero JM and Pozo D: The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs. 7:423–431. 2006.PubMed/NCBI | |
|
Calvo JR, González-Yanes C and Maldonado MD: The role of melatonin in the cells of the innate immunity: A review. J Pineal Res. 55:103–120. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A and Guerrero JM: Melatonin: Buffering the immune system. Int J Mol Sci. 14:8638–8683. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JG, Woo YS, Park SW, Seog DH, Seo MK and Bahk WM: The neuroprotective effects of melatonin: Possible role in the pathophysiology of neuropsychiatric disease. Brain Sci. 9:2852019. View Article : Google Scholar : PubMed/NCBI | |
|
Won E, Na KS and Kim YK: Associations between melatonin, neuroinflammation, and brain alterations in depression. Int J Mol Sci. 23:3052021. View Article : Google Scholar | |
|
Tozihi M, Shademan B, Yousefi H, Avci CB, Nourazarian A and Dehghan G: Melatonin: A promising neuroprotective agent for cerebral ischemia-reperfusion injury. Front Aging Neurosci. 15:12275132023. View Article : Google Scholar : PubMed/NCBI | |
|
Srinivasan V, Pandi-Perumal SR, Cardinali DP, Poeggeler B and Hardeland R: Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behav Brain Funct. 2:152006. View Article : Google Scholar : PubMed/NCBI | |
|
Reiter RJ, Tamura H, Tan DX and Xu XY: Melatonin and the circadian system: Contributions to successful female reproduction. Fertil Steril. 102:321–328. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Aversa S, Pellegrino S, Barberi I, Reiter RJ and Gitto E: Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J Matern Fetal Neonatal Med. 25:207–221. 2012. View Article : Google Scholar | |
|
Olcese JM: Melatonin and female reproduction: An expanding universe. Front Endocrinol (Lausanne). 11:852020. View Article : Google Scholar : PubMed/NCBI | |
|
Benowitz NL: Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 49:57–71. 2009. View Article : Google Scholar | |
|
De Biasi M and Dani JA: Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci. 34:105–130. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Chen X, Gong J and Yan Y: Relationships between stress, negative emotions, resilience, and smoking: Testing a moderated mediation model. Subst Use Misuse. 51:427–438. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Stevenson JG, Oliver JA, Hallyburton MB, Sweitzer MM, Conklin CA and McClernon FJ: Smoking environment cues reduce ability to resist smoking as measured by a delay to smoking task. Addict Behav. 67:49–52. 2017. View Article : Google Scholar : | |
|
Roy A, Rawal I, Jabbour S and Prabhakaran D: Chapter 4: Tobacco and cardiovascular disease: A summary of evidence. Cardiovascular Respiratory, and Related Disorders. Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y and Nugent R: 3rd edition. The International Bank for Reconstruction and Development/The World Bank; Washington, DC: 2017 | |
|
Liu CC and Yeh HI: Nicotine: A double-edged sword in atherosclerotic disease. Acta Cardiol Sin. 30:108–113. 2014.PubMed/NCBI | |
|
Benowitz NL and Burbank AD: Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 26:515–523. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Strzelak A, Ratajczak A, Adamiec A and Feleszko W: Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review. Int J Environ Res Public Health. 15:10332018. View Article : Google Scholar : PubMed/NCBI | |
|
Mishra A, Chaturvedi P, Datta S, Sinukumar S, Joshi P and Garg A: Harmful effects of nicotine. Indian J Med Paediatr Oncol. 36:24–31. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Grando SA: Connections of nicotine to cancer. Nat Rev Cancer. 14:419–429. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Caliri AW, Tommasi S and Besaratinia A: Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res Rev Mutat Res. 787:1083652021. View Article : Google Scholar : PubMed/NCBI | |
|
Chang CM, Corey CG, Rostron BL and Apelberg BJ: Systematic review of cigar smoking and all cause and smoking related mortality. BMC Public Health. 15:3902015. View Article : Google Scholar : PubMed/NCBI | |
|
Kim AS, Ko HJ, Kwon JH and Lee JM: Exposure to secondhand smoke and risk of cancer in never smokers: A meta-analysis of epidemiologic studies. Int J Environ Res Public Health. 15:19812018. View Article : Google Scholar : PubMed/NCBI | |
|
El-Sherbiny NA and Elsary AY: Smoking and nicotine dependence in relation to depression, anxiety, and stress in Egyptian adults: A cross-sectional study. J Family Community Med. 29:8–16. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Kutlu MG, Parikh V and Gould TJ: Nicotine addiction and psychiatric disorders. Int Rev Neurobiol. 124:171–208. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Albarrak DA, Alotaibi AB, Alotaibi RF, Alramadhan SH, Bin Muhanna AI, Aldehan AM and Bin Abdulrahman KA: The association between nicotine dependence and mental health in the general population of Saudi Arabia: A cross-sectional analytical study. Int J Gen Med. 16:5801–5815. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Cecon E, Oishi A and Jockers R: Melatonin receptors: Molecular pharmacology and signalling in the context of system bias. Br J Pharmacol. 175:3263–3280. 2018. View Article : Google Scholar : | |
|
Doghramji K: Melatonin and its receptors: A new class of sleep-promoting agents. J Clin Sleep Med. 3(Suppl 5): S17–S23. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Healy KL, Morris AR and Liu AC: Circadian synchrony: Sleep, nutrition, and physical activity. Front Netw Physiol. 1:7322432021. View Article : Google Scholar | |
|
Sato TK, Yamada RG, Ukai H, Baggs JE, Miraglia LJ, Kobayashi TJ, Welsh DK, Kay SA, Ueda HR and Hogenesch JB: Feedback repression is required for mammalian circadian clock function. Nat Genet. 38:312–319. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rahman SA, St Hilaire MA, Chang AM, Santhi N, Duffy JF, Kronauer RE, Czeisler CA, Lockley SW and Klerman EB: Circadian phase resetting by a single short-duration light exposure. JCI Insight. 2:e894942017. View Article : Google Scholar : PubMed/NCBI | |
|
Schwartz MD and Kilduff TS: The neurobiology of sleep and wakefulness. Psychiatr Clin North Am. 38:615–644. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wright KP, Lowry CA and Lebourgeois MK: Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci. 5:502012. View Article : Google Scholar : PubMed/NCBI | |
|
Valdés-Tovar M, Estrada-Reyes R, Solís-Chagoyán H, Argueta J, Dorantes-Barrón AM, Quero-Chávez D, Cruz-Garduño R, Cercós MG, Trueta C, Oikawa-Sala J, et al: Circadian modulation of neuroplasticity by melatonin: A target in the treatment of depression. Br J Pharmacol. 175:3200–3208. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Boiko DI, Shkodina AD, Hasan MM, Bardhan M, Kazmi SK, Chopra H, Bhutra P, Baig AA and Skrypnikov AM: Melatonergic receptors (Mt1/Mt2) as a potential additional target of novel drugs for depression. Neurochem Res. 47:2909–2924. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Mehraein F, Talebi R, Jameie B, Joghataie MT and Madjd Z: Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats. Iran Biomed J. 15:44–50. 2011.PubMed/NCBI | |
|
Shukla M, Govitrapong P, Boontem P, Reiter RJ and Satayavivad J: Mechanisms of melatonin in alleviating Alzheimer's disease. Curr Neuropharmacol. 15:1010–1031. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kim J, Li W, Wang J, Baranov SV, Heath BE, Jia J, Suofu Y, Baranova OV, Wang X, Larkin TM, et al: Biosynthesis of neuroprotective melatonin is dysregulated in Huntington's disease. J Pineal Res. 75:e129092023. View Article : Google Scholar : PubMed/NCBI | |
|
Laudon M and Frydman-Marom A: Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders. Int J Mol Sci. 15:15924–15950. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kostoglou-Athanassiou I: Therapeutic applications of melatonin. Ther Adv Endocrinol Metab. 4:13–24. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Scofield MD, Heinsbroek JA, Gipson CD, Kupchik YM, Spencer S, Smith ACW, Roberts-Wolfe D and Kalivas PW: The nucleus accumbens: Mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharmacol Rev. 68:816–871. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ekmekcioglu C: Melatonin receptors in humans: Biological role and clinical relevance. Biomed Pharmacother. 60:97–108. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Leeboonngam T, Pramong R, Sae-Ung K, Govitrapong P and Phansuwan-Pujito P: Neuroprotective effects of melatonin on amphetamine-induced dopaminergic fiber degeneration in the hippocampus of postnatal rats. J Pineal Res. 64:e124562018. View Article : Google Scholar | |
|
Sae-Ung K, Uéda K, Govitrapong P and Phansuwan-Pujito P: Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats. J Pineal Res. 52:128–137. 2012. View Article : Google Scholar | |
|
Quintero GC: Role of nucleus accumbens glutamatergic plasticity in drug addiction. Neuropsychiatr Dis Treat. 9:1499–1512. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Evely KM, Hudson RL, Dubocovich ML and Haj-Dahmane S: Melatonin receptor activation increases glutamatergic synaptic transmission in the rat medial lateral habenula. Synapse. 70:181–186. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang DD, Jin MF, Zhao DJ and Ni H: Reduction of mitophagy-related oxidative stress and preservation of mitochondria function using melatonin therapy in an HT22 hippocampal neuronal cell model of glutamate-induced excitotoxicity. Front Endocrinol (Lausanne). 10:5502019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang C, An Y, Xia Z, Zhou X, Li H, Song S, Ding L and Xia X: The neuroprotective effect of melatonin in glutamate excitotoxicity of R28 cells and mouse retinal ganglion cells. Front Endocrinol (Lausanne). 13:9861312022. View Article : Google Scholar : PubMed/NCBI | |
|
Jia S, Guo X, Chen Z, Li S and Liu XA: The roles of the circadian hormone melatonin in drug addiction. Pharmacol Res. 183:1063712022. View Article : Google Scholar : PubMed/NCBI | |
|
Li X and Slesinger PA: GABAB receptors and drug addiction: Psychostimulants and other drugs of abuse. Curr Top Behav Neurosci. 52:119–155. 2022. View Article : Google Scholar | |
|
Kalsbeek A, Garidou ML, Palm IF, Van Der Vliet J, Simonneaux V, Pévet P and Buijs RM: Melatonin sees the light: Blocking GABA-ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin. Eur J Neurosci. 12:3146–3154. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng XP, Sun H, Ye ZY and Zhou JN: Melatonin modulates the GABAergic response in cultured rat hippocampal neurons. J Pharmacol Sci. 119:177–185. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sari Y, Johnson VR and Weedman JM: Role of the serotonergic system in alcohol dependence: From animal models to clinics. Prog Mol Biol Transl Sci. 98:401–443. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Míguez JM, Simonneaux V and Pévet P: Evidence for a regulatory role of melatonin on serotonin release and uptake in the pineal gland. J Neuroendocrinol. 7:949–956. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Micale V, Arezzi A, Rampello L and Drago F: Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission. Eur Neuropsychopharmacol. 16:538–545. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Befort K: Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies. Front Pharmacol. 6:62015.PubMed/NCBI | |
|
Fields HL and Margolis EB: Understanding opioid reward. Trends Neurosci. 38:217–225. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dai X, Cui SG, Li SR, Chen Q and Wang R: Melatonin attenuates the development of antinociceptive tolerance to delta-, but not to mu-opioid receptor agonist in mice. Behav Brain Res. 182:21–27. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
El-Shenawy SM, Abdel-Salam OM, Baiuomy AR, El-Batran S and Arbid MS: Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res. 46:235–243. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Van Drunen R and Eckel-Mahan K: Circadian rhythms of the hypothalamus: From function to physiology. Clocks Sleep. 3:189–226. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
McLaughlin I, Dani JA and De Biasi M: Nicotine withdrawal. Curr Top Behav Neurosci. 24:99–123. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Logan RW, Williams WP III and McClung CA: Circadian rhythms and addiction: Mechanistic insights and future directions. Behav Neurosci. 128:387–412. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hasler BP, Smith LJ, Cousins JC and Bootzin RR: Circadian rhythms, sleep, and substance abuse. Sleep Med Rev. 16:67–81. 2012. View Article : Google Scholar | |
|
Cho YM, Kim HR, Kang MY, Myong JP and Koo JW: Fixed night workers and failed smoking cessation. J Occup Med Toxicol. 14:232019. View Article : Google Scholar : PubMed/NCBI | |
|
Cardinali DP, Brown GM and Pandi-Perumal SR: Chronotherapy. Handb Clin Neurol. 179:357–370. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Bae MJ, Song YM, Shin JY, Choi BY, Keum JH and Lee EA: The association between shift work and health behavior: Findings from the Korean national health and nutrition examination survey. Korean J Fam Med. 38:86–92. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Short NA, Mathes BM, Gibby B, Oglesby ME, Zvolensky MJ and Schmidt NB: Insomnia symptoms as a risk factor for cessation failure following smoking treatment. Addict Res Theory. 25:17–23. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Perreau-Lenz S and Spanagel R: Clock genes × stress × reward interactions in alcohol and substance use disorders. Alcohol. 49:351–357. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Saad L, Zwiller J, Kalsbeek A and Anglard P: Epigenetic regulation of circadian clocks and its involvement in drug addiction. Genes (Basel). 12:12632021. View Article : Google Scholar : PubMed/NCBI | |
|
Lewis RG, Florio E, Punzo D and Borrelli E: The Brain's reward system in health and disease. Adv Exp Med Biol. 1344:57–69. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wittenberg RE, Wolfman SL, De Biasi M and Dani JA: Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction. Neuropharmacology. 177:1082562020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiloha RC: Biological basis of tobacco addiction: Implications for smoking-cessation treatment. Indian J Psychiatry. 52:301–307. 2010. View Article : Google Scholar | |
|
Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M and Qin L: Melatonin as an antioxidant: Under promises but over delivers. J Pineal Res. 61:253–278. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Datta PC and King MG: Melatonin: Effects on brain and behavior. Neurosci Biobehav Rev. 4:451–458. 1980. View Article : Google Scholar : PubMed/NCBI | |
|
Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S and Khadijeh M: Effect of melatonin supplementation on sleep quality: A systematic review and meta-analysis of randomized controlled trials. J Neurol. 269:205–216. 2022. View Article : Google Scholar | |
|
Foley HM and Steel AE: Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complement Ther Med. 42:65–81. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Motooka Y, Matsui T, Slaton RM, Umetsu R, Fukuda A, Naganuma M, Hasegawa S, Sasaoka S, Hatahira H, Iguchi K and Nakamura M: Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the food and drug administration adverse event reporting system, 2004-2016. SAGE Open Med. 6:20503121187779532018. View Article : Google Scholar : PubMed/NCBI | |
|
Erland LAE and Saxena PK: Melatonin natural health products and supplements: Presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 13:275–281. 2017. View Article : Google Scholar : | |
|
Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M and Dubocovich ML: MT1 and MT2 melatonin receptors: A therapeutic perspective. Annu Rev Pharmacol Toxicol. 56:361–383. 2016. View Article : Google Scholar : | |
|
Giulietti F, Filipponi A, Rosettani G, Giordano P, Iacoacci C, Spannella F and Sarzani R: Pharmacological approach to smoking cessation: An updated review for daily clinical practice. High Blood Press Cardiovasc Prev. 27:349–362. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Perkins KA, Conklin CA and Levine MD: Cognitive-behavioral therapy for smoking cessation: A practical guidebook to the most effective treatments. 1st edition. Routledge; New York, NY: 2007 | |
|
Shirani A and St Louis EK: Illuminating rationale and uses for light therapy. J Clin Sleep Med. 5:155–163. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Patterson F, Grandner MA, Malone SK, Rizzo A, Davey A and Edwards DG: Sleep as a target for optimized response to smoking cessation treatment. Nicotine Tob Res. 21:139–148. 2019. View Article : Google Scholar : | |
|
Silva ACPE, Santos MJD, Koike BDV, Moreira MSA, Gitai DLG, de Miranda Coelho JAP and de Andrade TG: Melatonin receptor 1B-1193T>C polymorphism is associated with diurnal preference and sleep habits. Sleep Med. 53:106–114. 2019. View Article : Google Scholar | |
|
Sulkava S, Ollila HM, Alasaari J, Puttonen S, Härmä M, Viitasalo K, Lahtinen A, Lindström J, Toivola A, Sulkava R, et al: Common genetic variation near melatonin receptor 1A gene linked to job-related exhaustion in shift workers. Sleep. 40:zsw0112017. View Article : Google Scholar : PubMed/NCBI | |
|
Pandi-Perumal SR, Zisapel N, Srinivasan V and Cardinali DP: Melatonin and sleep in aging population. Exp Gerontol. 40:911–925. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Shechter A and Boivin DB: Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder. Int J Endocrinol. 2010:2593452010. View Article : Google Scholar : PubMed/NCBI | |
|
Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C and Pickworth WB: Gender differences in acute tobacco withdrawal: Effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol. 15:21–36. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Repova K, Baka T, Krajcirovicova K, Stanko P, Aziriova S, Reiter RJ and Simko F: Melatonin as a potential approach to anxiety treatment. Int J Mol Sci. 23:161872022. View Article : Google Scholar : PubMed/NCBI | |
|
Touitou Y, Reinberg A and Touitou D: Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: Health impacts and mechanisms of circadian disruption. Life Sci. 173:94–106. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
English J, Arendt J, Poulton A and Symons AM: Short-term variations of circulating melatonin in the ewe. J Pineal Res. 4:359–366. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Cozzi B, Ravault JP, Ferrandi B and Reiter RJ: Melatonin concentration in the cerebral vascular sinuses of sheep and evidence for its episodic release. J Pineal Res. 5:535–543. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Rzepka-Migut B and Paprocka J: Melatonin-measurement methods and the factors modifying the results. A systematic review of the literature. Int J Environ Res Public Health. 17:19162020. View Article : Google Scholar : PubMed/NCBI | |
|
Benloucif S, Burgess HJ, Klerman EB, Lewy AJ, Middleton B, Murphy PJ, Parry BL and Revell VL: Measuring melatonin in humans. J Clin Sleep Med. 4:66–69. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Florescu A, Ferrence R, Einarson T, Selby P, Soldin O and Koren G: Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: Focus on developmental toxicology. Ther Drug Monit. 31:14–30. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N and Fougerou C: Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 15:434–443. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Valentine JA: The transformative role of authentic partnership in the tuskegee public health ethics program. J Healthc Sci Humanit. 8:21–29. 2018.PubMed/NCBI | |
|
Minichino A, Bersani FS, Calò WK, Spagnoli F, Francesconi M, Vicinanza R, Delle Chiaie R and Biondi M: Smoking behaviour and mental health disorders-mutual influences and implications for therapy. Int J Environ Res Public Health. 10:4790–4811. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Caruana EJ, Roman M, Hernández-Sánchez J and Solli P: Longitudinal studies. J Thorac Dis. 7:E537–E540. 2015.PubMed/NCBI | |
|
Yip C, Han NR and Sng BL: Legal and ethical issues in research. Indian J Anaesth. 60:684–688. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Faber J and Fonseca LM: How sample size influences research outcomes. Dental Press J Orthod. 19:27–29. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hariton E and Locascio JJ: Randomised controlled trials-the gold standard for effectiveness research: Study design: Randomised controlled trials. BJOG. 125:17162018. View Article : Google Scholar | |
|
Lim CY and In J: Considerations for crossover design in clinical study. Korean J Anesthesiol. 74:293–299. 2021. View Article : Google Scholar : PubMed/NCBI |
